These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1). Schneider DJ; Hayes M; Wadsworth M; Taatjes H; Rincón M; Taatjes DJ; Sobel BE J Histochem Cytochem; 2004 Aug; 52(8):1091-9. PubMed ID: 15258185 [TBL] [Abstract][Full Text] [Related]
3. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. Xiong Y; Yu Y; Montani JP; Yang Z; Ming XF J Am Heart Assoc; 2013 Jul; 2(4):e000096. PubMed ID: 23832324 [TBL] [Abstract][Full Text] [Related]
4. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ; Waseem TC; Galkina EV Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405 [TBL] [Abstract][Full Text] [Related]
10. Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability. Lyon CA; Johnson JL; Williams H; Sala-Newby GB; George SJ Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):195-201. PubMed ID: 19008530 [TBL] [Abstract][Full Text] [Related]
11. The angiotensin receptor blocker, azilsartan medoxomil (TAK-491), suppresses vascular wall expression of plasminogen activator inhibitor type-I protein potentially facilitating the stabilization of atherosclerotic plaques. French CJ; Zaman AK; Sobel BE J Cardiovasc Pharmacol; 2011 Aug; 58(2):143-8. PubMed ID: 21558880 [TBL] [Abstract][Full Text] [Related]
12. Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice. Cao RY; Eves R; Jia L; Funk CD; Jia Z; Mak AS PLoS One; 2017; 12(3):e0175061. PubMed ID: 28362832 [TBL] [Abstract][Full Text] [Related]
13. The P2Y Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380 [TBL] [Abstract][Full Text] [Related]
14. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype. Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690 [TBL] [Abstract][Full Text] [Related]
15. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability. Shai SY; Sukhanov S; Higashi Y; Vaughn C; Kelly J; Delafontaine P Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1916-24. PubMed ID: 20671230 [TBL] [Abstract][Full Text] [Related]
16. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651 [TBL] [Abstract][Full Text] [Related]